3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
4
Phase 4
2
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Osteoporosis
2
Breast Neoplasms
2
Bone Diseases, Metabolic
2
Prostatic Neoplasms
1
Interventions
Letrozole
20
Docetaxel
16
Cyclophosphamide
13
Zoledronic Acid
12
exemestane
11
Trastuzumab
11
Anastrozole
11
Paclitaxel
10
Tamoxifen
9
Capecitabine
9
Fulvestrant
8
Epirubicin
8
pegfilgrastim
7
pertuzumab
6
liposomal doxorubicin
6
abemaciclib
6
Saline Solution
6
palbociclib
5
Sodium Chloride
5
Dexmedetomidine
5
Carboplatin
5
Bupivacaine
5
Bevacizumab
5
ribociclib
4
pegylated granulocyte colony-stimulating factor
4
eribulin
4
Tranexamic Acid
4
Standard of Care
4
Pamidronate
4
Filgrastim
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Breast Neoplasms
×
Risedronic Acid
×
Clear all
NCT00485953
2017-10-13
REBBeCA II
University of Pittsburgh
Phase 4
Completed
109 enrolled
11 charts
NCT00082277
2011-01-26
SABRE
AstraZeneca
Phase 4
Completed
237 enrolled